Osaic Holdings’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-290
| Closed | -$16.5K | – | 7528 |
|
|
2023
Q4 | $16.5K | Sell |
290
-2,910
| -91% | -$164K | ﹤0.01% | 5594 |
|
|
2023
Q3 | $139K | Buy |
3,200
+1,363
| +74% | +$48.7K | ﹤0.01% | 4255 |
|
|
2023
Q2 | $66.6K | Sell |
1,837
-68
| -4% | -$2.8K | ﹤0.01% | 4747 |
|
|
2023
Q1 | $70.8K | Sell |
1,905
-335
| -15% | -$15.1K | ﹤0.01% | 4721 |
|
|
2022
Q4 | $100K | Buy |
2,240
+721
| +47% | +$46.7K | ﹤0.01% | 4426 |
|
|
2022
Q3 | $105K | Buy |
1,519
+43
| +3% | +$3.18K | ﹤0.01% | 4331 |
|
|
2022
Q2 | $99K | Buy |
1,476
+832
| +129% | +$52.9K | ﹤0.01% | 4436 |
|
|
2022
Q1 | $52K | Buy |
644
+437
| +211% | +$44.7K | ﹤0.01% | 5073 |
|
|
2021
Q4 | $29K | Sell |
207
-281
| -58% | -$43.6K | ﹤0.01% | 5538 |
|
|
2021
Q3 | $87K | Buy |
488
+178
| +57% | +$28.6K | ﹤0.01% | 4654 |
|
|
2021
Q2 | $50K | Sell |
310
-38
| -11% | -$6.1K | ﹤0.01% | 5048 |
|
|
2021
Q1 | $59K | Buy |
348
+13
| +4% | +$2.57K | ﹤0.01% | 4768 |
|
|
2020
Q4 | $73K | Sell |
335
-119
| -26% | -$25.7K | ﹤0.01% | 4282 |
|
|
2020
Q3 | $76K | Buy |
454
+108
| +31% | +$14.8K | ﹤0.01% | 4027 |
|
|
2020
Q2 | $39K | Sell |
346
-20,380
| -98% | -$1.98M | ﹤0.01% | 4377 |
|
|
2020
Q1 | $28K | Buy |
+20,726
| New | +$1.86M | ﹤0.01% | 4424 |
|
Other funds holding MRTX
Osaic Holdings's MRTX Position: Q1 2024 in Review
Osaic Holdings sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 290 shares — an estimated $16.5K sold.
Osaic Holdings first reported a position in MRTX in Q1 2020 and held it in 16 quarters. The position peaked at $139K in Q3 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Osaic Holdings reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Osaic Holdings sold 290 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $16.5K.
- Osaic Holdings first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2020 and held it in 16 quarters.
- Osaic Holdings's Mirati Therapeutics, Inc. Common Stock position peaked at $139K in Q3 2023.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Osaic Holdings's 13F filing for Q1 2024, filed 10 May 2024.